William Conkling
CIK: 0001852018
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jun 9, 2026IDT
IDT CORP
Award(A)Direct673 shares at avg. $55.75$38K - Jun 2, 2026TARA
Protara Therapeutics, Inc.
Tax Payment(F)Direct6K shares at avg. $4.34$26K - Jan 16, 2026TARA
Protara Therapeutics, Inc.
Award(A)Direct26K shares- - Jun 2, 2025TARA
Protara Therapeutics, Inc.
Award(A)Direct50K shares- - Mar 25, 2025RFL
Rafael Holdings, Inc.
Award(A)Direct27.5K shares- - Mar 21, 2025RFL
Rafael Holdings, Inc.
Tax Payment(F)Direct14.8K shares at avg. $1.93$29K - Feb 27, 2025CYTH
Cyclo Therapeutics, Inc.
Award(A)Direct27.7K shares- - Jan 13, 2025RFL
Rafael Holdings, Inc.
Award(A)Direct60K shares at avg. $1.95$117K - Dec 21, 2024RFL
Rafael Holdings, Inc.
Tax Payment(F)Direct12.8K shares at avg. $1.83$24K - Nov 15, 2024CYTH
Cyclo Therapeutics, Inc.
Award(A)Direct16.7K shares- - Oct 25, 2024RFL
Rafael Holdings, Inc.
Tax Payment(F)Direct3.4K shares at avg. $1.84$6K - Sep 21, 2024RFL
Rafael Holdings, Inc.
Tax Payment(F)Direct12.7K shares at avg. $1.73$22K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 |  IDT IDT CORP | Award(A) | 673 | $55.75 | $37,520 | Direct |
| Jun 2, 2026 |  TARA Protara Therapeutics, Inc. | Tax Payment(F) | 6,008 | $4.34 | $26,075 | Direct |
| Jan 16, 2026 | TARA Protara Therapeutics, Inc. | Award(A) | 26,000 | - | $0 | Direct |
| Jun 2, 2025 | TARA Protara Therapeutics, Inc. | Award(A) | 50,000 | - | - | Direct |
| Mar 25, 2025 |  RFL Rafael Holdings, Inc. | Award(A) | 27,454 | - | - | Direct |
| Mar 21, 2025 | RFL Rafael Holdings, Inc. | Tax Payment(F) | 14,814 | $1.93 | $28,591 | Direct |
| Feb 27, 2025 |  CYTH Cyclo Therapeutics, Inc. | Award(A) | 27,654 | - | - | Direct |
| Jan 13, 2025 | RFL Rafael Holdings, Inc. | Award(A) | 60,000 | $1.95 | $117,240 | Direct |
| Dec 21, 2024 | RFL Rafael Holdings, Inc. | Tax Payment(F) | 12,807 | $1.83 | $23,501 | Direct |
| Nov 15, 2024 | CYTH Cyclo Therapeutics, Inc. | Award(A) | 16,660 | - | $0 | Direct |
| Oct 25, 2024 | RFL Rafael Holdings, Inc. | Tax Payment(F) | 3,431 | $1.84 | $6,313 | Direct |
| Sep 21, 2024 | RFL Rafael Holdings, Inc. | Tax Payment(F) | 12,696 | $1.73 | $21,901 | Direct |
1-12 of 12 transactions
About CONKLING WILLIAM
CONKLING WILLIAM (SEC CIK 0001852018) files insider reports with the SEC as Director of IDT CORP (IDT), Chief Commercial Officer of Protara Therapeutics, Inc. (TARA) and Chief Executive Officer of Rafael Holdings, Inc. (RFL). Signal8 also holds filings tied to 1 other company.
Signal8 holds 14 ownership filings by CONKLING WILLIAM (2 Form 3, 12 Form 4), filed between Sep 24, 2024 and Jun 11, 2026. Those filings report 12 transactions, from Sep 21, 2024 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on CONKLING WILLIAM's filings is in NEW YORK, NY.
Recent filings by CONKLING WILLIAM
- Jun 9, 2026: Grant or award of IDT shares (Form 4, code A).
- Jun 2, 2026: Tax withholding of TARA shares (Form 4, code F).
- Jan 16, 2026: Grant or award of TARA shares (Form 4, code A).
- Jun 2, 2025: Grant or award of TARA shares (Form 4, code A).
- Mar 25, 2025: Grant or award of RFL shares (Form 4, code A).
Other insiders filing for IDT CORP (IDT)
- FISCHER MARCELO, Chief Financial Officer
- SHEA NADINE, EVP of GLOBAL HUMAN RESOURCES
- ASH MENACHEM, EVP of Strategic&Legal Affairs
- SCHORR JUDAH, Director
- SILBERMAN MITCH, CAO & Controller
- MASON JOYCE J, EVP and Corporate Secretary